These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7545249)

  • 1. A screen in Escherichia coli for nucleoside analogs that target human immunodeficiency virus (HIV) reverse transcriptase: coexpression of HIV reverse transcriptase and herpes simplex virus thymidine kinase.
    Kim B; Loeb LA
    J Virol; 1995 Oct; 69(10):6563-6. PubMed ID: 7545249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus reverse transcriptase substitutes for DNA polymerase I in Escherichia coli.
    Kim B; Loeb LA
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):684-8. PubMed ID: 7531338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecificity of human DNA polymerases alpha, beta, gamma, delta and epsilon, HIV-reverse transcriptase, HSV-1 DNA polymerase, calf thymus terminal transferase and Escherichia coli DNA polymerase I in recognizing D- and L-thymidine 5'-triphosphate as substrate.
    Focher F; Maga G; Bendiscioli A; Capobianco M; Colonna F; Garbesi A; Spadari S
    Nucleic Acids Res; 1995 Aug; 23(15):2840-7. PubMed ID: 7544886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus reverse transcriptase. Functional mutants obtained by random mutagenesis coupled with genetic selection in Escherichia coli.
    Kim B; Hathaway TR; Loeb LA
    J Biol Chem; 1996 Mar; 271(9):4872-8. PubMed ID: 8617758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases.
    Cheng YC; Dutschman G; Fox JJ; Watanabe KA; Machida H
    Antimicrob Agents Chemother; 1981 Sep; 20(3):420-3. PubMed ID: 6272634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cloning, expression, isolation and properties of thymidine kinase herpes simplex virus, strain L2].
    Stepanenko VN; Esipov R; Miroshnikov AI; Andronova VL; Galegov GA; Ias'ko MV; Gus'kova AV; Skoblov AIu; Skoblov IuS
    Bioorg Khim; 2011; 37(4):490-5. PubMed ID: 22096991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
    Im GJ; Tramontano E; Gonzalez CJ; Cheng YC
    Biochem Pharmacol; 1993 Dec; 46(12):2307-13. PubMed ID: 7506027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate.
    Tan CK; Civil R; Mian AM; So AG; Downey KM
    Biochemistry; 1991 May; 30(20):4831-5. PubMed ID: 1709809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of resistance mutants of viral polymerases.
    Oxford JS; al-Jabri AA; Stein CA; Levantis P
    Methods Enzymol; 1996; 275():555-600. PubMed ID: 9026659
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
    Tisdale M; Kemp SD; Parry NR; Larder BA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs.
    Cheng YC; Dutschman GE; Bastow KF; Sarngadharan MG; Ting RY
    J Biol Chem; 1987 Feb; 262(5):2187-9. PubMed ID: 2434477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside analogs as non-substrate inhibitors of herpes simplex viruses thymidine kinase.
    Focher F; Sandoli D; Hildebrand C; Sangalli S; Ciarrocchi G; Rebuzzini A; Pedrali-Noy G; Manservigi R; Wright G; Brown N
    Methods Find Exp Clin Pharmacol; 1989 Sep; 11(9):577-82. PubMed ID: 2555637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of HIV reverse transcriptase: a target for the design of specific virus inhibitors.
    Tisdale M; Larder BA; Lowe DM; Stammers DK; Purifoy DJ; Ertl P; Bradley C; Kemp S; Darby GK; Powell KL
    J Antimicrob Chemother; 1989 Jan; 23 Suppl A():47-54. PubMed ID: 2469675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-acyl-2-thioethyl (SATE) pronucleotides are potent inhibitors of HIV-1 replication in T-lymphoid cells cross-resistant to deoxycytidine and thymidine analogs.
    Gröschel B; Cinatl J; Périgaud C; Gosselin G; Imbach JL; Doerr HW; Cinatl J
    Antiviral Res; 2002 Feb; 53(2):143-52. PubMed ID: 11750940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
    Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors.
    Balzarini J; Weeger M; Camarasa MJ; De Clercq E; Uberla K
    Biochem Biophys Res Commun; 1995 Jun; 211(3):850-6. PubMed ID: 7541200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.
    Arts EJ; Marois JP; Gu Z; Le Grice SF; Wainberg MA
    J Virol; 1996 Feb; 70(2):712-20. PubMed ID: 8551607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
    Anderson KS
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants.
    Boyer PL; Julias JG; Ambrose Z; Siddiqui MA; Marquez VE; Hughes SH
    J Mol Biol; 2007 Aug; 371(4):873-82. PubMed ID: 17597154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.